Tezepelumab
Tezepelumab is a pharmaceutical drug with 38 clinical trials. Currently 16 active trials ongoing. Historical success rate of 88.2%.
Success Metrics
Based on 15 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
8
Mid Stage
19
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
88.2%
15 of 17 finished
11.8%
2 ended early
16
trials recruiting
38
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Physical Activity Promotion and Clinical Remission in Severe Asthma
Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis
Tezspire Cardiac Events PASS
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Observational Study on the Clinical Profile of Patients With Uncontrolled Severe Asthma Treated With Tezepelumab in Italy
Clinical Trials (38)
Physical Activity Promotion and Clinical Remission in Severe Asthma
Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis
Tezspire Cardiac Events PASS
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Observational Study on the Clinical Profile of Patients With Uncontrolled Severe Asthma Treated With Tezepelumab in Italy
Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)
Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States
A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab
REVErsing Airway Remodelling With Tezepelumab
Efficacy of Tezepelumab in Peanut Oral Immunotherapy
Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma
Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.
A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With Tezepelumab
Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis
Patient Characteristics, Treatment Patterns and Outcomes of Patients With Severe Asthma Treated With Tezepelumab in the Real World; a Retrospective, Observational Medical Chart Review Conducted in UK Severe Asthma Centres
Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS)
Tezepelumab on Airway Structure and Function in Patients With Uncontrolled Moderate-to-severe Asthma
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 38